pharmaphorum| News & views on pharma and biotech’s evolving future

R&D

a scientist in the lab holds a white mouse model in their gloved hands

Beyond animal testing: How human data trials are reshaping d...

Researchers are beginning to imagine a future in which development pipelines are more predictive, more efficient, and ultimately more humane.

R&D

black lady smiling and looking at laptop

Working together to innovate on pragmatic clinical trials, w...

In today’s episode, host Jonah Comstock speaks with Rob DiCicco, vice president of portfolio management at TransCelerate Biopharma.

Spotlight on

Frontiers Health 2025

News

GSK pumps £45m into antimicrobial resistance projects

GSK has revealed the six projects it will fund with the Fleming Initiative on antimicrobial resistance, set up with Imperial College London last year.

News

Roche extols 'unprecedented' result with breast cancer drug

Roche's oral SERD giredestrant has achieved what the company says is a stellar result as adjuvant treatment for early breast cancer.

Featured Content

R&D

Beyond animal testing: How human data trials are reshaping d...

Researchers are beginning to imagine a future in which development pipelines are more predictive, more efficient, and ultimately more humane.

Spotlight on

Frontiers Health 2025

/themes/custom/pharmaphorum_theme/library/img/article-label-image/register.png

Sales & Marketing

Physicians walking and using tablet devices

Sponsored

How to meet your physicians where they are online

A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.

R&D

Working together to innovate on pragmatic clinical trials, w...

In today’s episode, host Jonah Comstock speaks with Rob DiCicco, vice president of portfolio management at TransCelerate Biopharma.

Oncology

Interview at ESMO 2025 with Sandeep Reddy, Immunity Bio

ESMO25: Harnessing the innate and the adaptive immune respon...

As ESMO 2025 came to a close last month, pharmaphorum had the pleasure of catching up with Dr Sandeep Reddy, Chief Medical Officer at ImmunityBio.

R&D

A man stood on a rock looking towards the horizon

Sponsored

A New Framework to Engineer Breakthrough Value for Medicines

A new white paper from Lumanity – ‘A New Framework to Engineer Breakthrough Value for Medicines: Value Inflection Points Across the Development Path’.

Newsletters and Deep Dive
digital magazine

Latest News

News

GSK pumps £45m into antimicrobial resistance projects

GSK has revealed the six projects it will fund with the Fleming Initiative on antimicrobial resistance, set up with Imperial College London last year.

News

Roche extols 'unprecedented' result with breast cancer drug

Roche's oral SERD giredestrant has achieved what the company says is a stellar result as adjuvant treatment for early breast cancer.

News

New guidance covers AI-based biomarkers for cancer care

ESMO guidance on the validation and clinical use of AI-based biomarkers in oncology aims to strike a balance between caution and over-reliance.

News

Novo Nordisk cuts Wegovy price ahead of TrumpRx launch

Novo Nordisk has jumped the gun on US price reductions for its blockbuster diabetes and weight-loss drug semaglutide.

Views & Analysis

R&D

Beyond animal testing: How human data trials are reshaping d...

Researchers are beginning to imagine a future in which development pipelines are more predictive, more efficient, and ultimately more humane.

R&D

Knowledge Quarter, King's Cross, London, UK

From physics to pharma: How Aqemia is reinventing the future...

The UK life sciences sector has long been a crucible for innovation, blending academic excellence with a thriving ecosystem of biotech and pharmaceutical enterprises.

Oncology

ESMO25: Harnessing the innate and the adaptive immune respon...

As ESMO 2025 came to a close last month, pharmaphorum had the pleasure of catching up with Dr Sandeep Reddy, Chief Medical Officer at ImmunityBio.

Digital

Pharma’s new gatekeeper: AI’s rising role

The AI bouncer guarding the door of healthcare information isn’t going anywhere and isn’t changing its standards.

Deep Dive

Patients

Patients and Partnerships 2025

Patients

How DTP became pharma’s newest battleground

Patients

How to land a deal with big pharma

Patients

Beyond being heard: The patient voice as a force for change

White Papers & Webinar

Sales & Marketing

Sponsored

How to meet your physicians where they are online

A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.

R&D

Sponsored

A New Framework to Engineer Breakthrough Value for Medicines

A new white paper from Lumanity – ‘A New Framework to Engineer Breakthrough Value for Medicines: Value Inflection Points Across the Development Path’.

Digital

Sponsored

Future proofing production: Implementing AI in pharmaceutica...

Read Zühlke’s new white paper, ‘Future Proof Production: Implementing AI in pharmaceutical manufacturing’ today.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Digital

Sponsored

Tracking studies get smarter: AI meets human intelligence

Having a continuous pulse on brand health is essential for pharmaceutical companies to inform strategic decisions and establish Key Performance Indicators (KPIs) in an ever-changing market